BANK OF AMERICA CORP /DE/ - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 58 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$68,372
-9.7%
16,475
+4.6%
0.00%
Q2 2023$75,723
-33.0%
15,743
-43.5%
0.00%
Q1 2023$113,051
-45.8%
27,845
-27.9%
0.00%
Q4 2022$208,516
-7.7%
38,614
+71.1%
0.00%
Q3 2022$226,000
+71.2%
22,573
-19.7%
0.00%
Q2 2022$132,000
+29.4%
28,126
+7.9%
0.00%
Q1 2022$102,000
-28.7%
26,055
+23.5%
0.00%
Q4 2021$143,000
+921.4%
21,095
+2030.8%
0.00%
Q3 2021$14,0009900.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders